Nanjing Well Pharmaceutical Group Co.,Ltd. (SHA:603351)
China
· Delayed Price · Currency is CNY 26.52
-0.27 (-1.01%)
Mar 11, 2026, 11:29 AM CST
SHA:603351 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 10, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 3,628 | 3,326 | 3,572 | 2,930 | 5,118 | 2,979 | Upgrade
|
| Market Cap Growth | 11.30% | -6.86% | 21.88% | -42.75% | 71.80% | -9.60% | Upgrade
|
| Enterprise Value | 3,876 | 3,601 | 3,949 | 3,260 | 5,210 | 2,871 | Upgrade
|
| Last Close Price | 26.79 | 24.22 | 25.64 | 20.80 | 37.17 | 21.31 | Upgrade
|
| PE Ratio | 24.58 | 22.72 | 31.83 | 30.84 | 50.49 | 29.66 | Upgrade
|
| PS Ratio | 2.76 | 2.57 | 3.09 | 2.64 | 4.91 | 4.05 | Upgrade
|
| PB Ratio | 2.05 | 1.95 | 2.24 | 1.98 | 3.69 | 2.29 | Upgrade
|
| P/TBV Ratio | 2.20 | 2.09 | 2.40 | 2.11 | 3.92 | 2.44 | Upgrade
|
| P/FCF Ratio | 24.70 | 19.53 | 75.71 | - | - | - | Upgrade
|
| P/OCF Ratio | 17.75 | 15.00 | 29.70 | 26.89 | - | 31.93 | Upgrade
|
| EV/Sales Ratio | 2.95 | 2.78 | 3.42 | 2.94 | 5.00 | 3.90 | Upgrade
|
| EV/EBITDA Ratio | 11.98 | 13.05 | 19.72 | 18.05 | 32.14 | 20.17 | Upgrade
|
| EV/EBIT Ratio | 21.65 | 21.27 | 29.88 | 27.86 | 42.55 | 26.59 | Upgrade
|
| EV/FCF Ratio | 26.39 | 21.14 | 83.72 | - | - | - | Upgrade
|
| Debt / Equity Ratio | 0.35 | 0.28 | 0.31 | 0.29 | 0.14 | 0.09 | Upgrade
|
| Debt / EBITDA Ratio | 1.89 | 1.69 | 2.39 | 2.26 | 1.21 | 0.82 | Upgrade
|
| Debt / FCF Ratio | 4.16 | 2.83 | 10.32 | - | - | - | Upgrade
|
| Net Debt / Equity Ratio | 0.14 | 0.14 | 0.21 | 0.22 | 0.08 | -0.12 | Upgrade
|
| Net Debt / EBITDA Ratio | 0.77 | 0.85 | 1.64 | 1.80 | 0.66 | -1.10 | Upgrade
|
| Net Debt / FCF Ratio | 1.64 | 1.37 | 6.96 | -2.60 | -0.43 | 0.83 | Upgrade
|
| Asset Turnover | 0.54 | 0.56 | 0.52 | 0.56 | 0.60 | 0.48 | Upgrade
|
| Inventory Turnover | 5.15 | 5.04 | 5.02 | 5.27 | 5.92 | 4.47 | Upgrade
|
| Quick Ratio | 0.93 | 0.82 | 0.72 | 0.48 | 0.71 | 1.20 | Upgrade
|
| Current Ratio | 1.29 | 1.20 | 1.08 | 0.81 | 1.10 | 1.63 | Upgrade
|
| Return on Equity (ROE) | 8.48% | 8.80% | 7.10% | 6.59% | 7.46% | 7.91% | Upgrade
|
| Return on Assets (ROA) | 4.60% | 4.54% | 3.74% | 3.68% | 4.40% | 4.36% | Upgrade
|
| Return on Invested Capital (ROIC) | 7.33% | 7.39% | 6.37% | 5.93% | 7.83% | 9.34% | Upgrade
|
| Return on Capital Employed (ROCE) | 9.50% | 9.50% | 7.70% | 7.50% | 8.60% | 8.10% | Upgrade
|
| Earnings Yield | 4.07% | 4.40% | 3.14% | 3.24% | 1.98% | 3.37% | Upgrade
|
| FCF Yield | 4.05% | 5.12% | 1.32% | -4.26% | -4.83% | -6.35% | Upgrade
|
| Dividend Yield | 1.53% | 1.65% | 1.17% | 1.35% | 0.81% | 1.41% | Upgrade
|
| Payout Ratio | 45.24% | 37.88% | 47.61% | 56.70% | 44.64% | 46.87% | Upgrade
|
| Buyback Yield / Dilution | 0.43% | -0.29% | -1.00% | -0.35% | -2.25% | -1.83% | Upgrade
|
| Total Shareholder Return | 1.96% | 1.36% | 0.17% | 1.00% | -1.44% | -0.42% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.